Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Avandia (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 17
» View wsbtradio.com items only
    May 8, 2013 |Story| Reuters

  1. REUTERS SUMMIT-Drugmakers split as demands for open data mount

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Growing demands for transparency of clinical trial data * Wider disclosure by EU regulator angers drugmakers * GlaxoSmithKline sets up online system for data...

    Tags: Trials, Merck & Company Incorporated, Research, GlaxoSmithKline PLC, Pharmaceuticals

    2. Mar 25, 2013 |Story| Los Angeles Times

  2. Girardi | Keese

    Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...

    Tags: Trials, Crime, Law and Justice, Justice System, Actos (drug), Laws

    3. Feb 20, 2013 |Story| Baltimore Sun

  3. State AG sues maker of diabetes drugs for false advertising

    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market.
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...

    Tags: Trials, Diabetes, Heart Attack, Douglas F. Gansler, Crime, Law and Justice

    4. Aug 1, 2012 |Story| Chicago Tribune

  4. What drugs are going generic this year and next

    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic Pharmaceutical Association.
    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...

    Tags: Behavioral Conditions, Osteoporosis, Actos (drug), Sjogren's Syndrome, Cymbalta (drug)

    5. Jul 2, 2012 |Story| WPMT-LTV

  5. Pennsylvania to receive more than $13 million as part of GlaxoSmithKline healthcare fraud settlement

    Attorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history.
    Assistant Press Secretary
    Attorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history. Kelly said that GlaxoSmithKline, a British based pharmaceutical company that...

    Tags: Health Insurance, Behavioral Conditions, Paxil (drug), Marketing, Chemical Industry

    6. Jul 2, 2012 |Story| Los Angeles Times

  6. GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says

    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.
    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...

    Tags: Trials, Steve Jobs, Paxil (drug), Corporate Crime, Human Genome Sciences Inc.

    7. Feb 7, 2011 |Story| Reuters

  7. Glaxo adds safety restrictions to Avandia label

    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack.
    Reuters
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...

    Tags: Trials, Washington, DC, Heart Attack, Physical Conditions, GlaxoSmithKline PLC

    8. Sep 24, 2010 |Resource Link| Health Portal

  8. Government information about Avandia

    Tags: Pharmaceuticals

    9. Aug 30, 2007 |Story| Chicago Tribune

  9. Sales stay healthy for Takeda diabetes pill

    About one month after a Food and Drug Administration advisory panel said the diabetes pill Avandia should remain on the market but with strict warnings about heart attack risk, a similar pill sold by a Deerfield-based drugmaker is holding its own in the...

    Tags: Diseases and Illnesses, Heart Attack, Diabetes, Merck & Company Incorporated, Medical Services

    10. Jun 21, 2007 |Story| Chicago Tribune

  10. Diabetes pill's sales health in question

    Heading into this weekend's American Diabetes Association meeting in Chicago, industry analysts are predicting a continued decline of the diabetes pill Avandia. Avandia, sold by British drug giant GlaxoSmithKline PLC, has been losing market share in...

    Tags: Novartis AG, Japan, Heart Attack, Merck & Company Incorporated, Health

    11. Jun 4, 2007 |Story| Los Angeles Times

  11. Diabetics' risk of heart attack

    Special to The Times
    Some 15 million Americans have been diagnosed with Type 2 diabetes mellitus. About 85% take some form of medication or insulin to control it. Recently, scientists reported that one such drug, called Avandia, increased a diabetic's risk of heart attacks by...

    Tags: Death, Heart Attack, Obesity, Health, Pharmaceuticals

    12. Dec 4, 2009 | Los Angeles Times

  12. Sulfonylureas for diabetes increase risk of heart disease and death, study finds

    Booster Shots
    Sulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected......
 1  2 • Next >
Original site for Avandia (drug) topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Avandia (drug) Photos
The controversial diabetes drug Avandia will no longer...
(May 19, 2011)
FDA to limit availability of diabetes drug Avandia
6: The FDA said in September that it would sharply limi...
(October 20, 2010)
FDA limits access to Avandia